Carbonic anhydrase inhibitors: Stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II

被引:149
作者
Menchise, V
De Simone, G
Alterio, V
Di Fiore, A
Pedone, C
Scozzafava, A
Supuran, CT
机构
[1] CNR, Ist Biostrutture & Bioimmagini, I-80134 Naples, Italy
[2] Bioind Pk Canavese Spa, I-10010 Colleretto Giacosa, Torino, Italy
[3] Univ Naples Federico II, Dipartimento Sci Biol, Sez Biostrutture, I-80134 Naples, Italy
[4] Univ Florence, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Florence, Italy
关键词
D O I
10.1021/jm050333c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure for the adduct of carbonic anhydrase II with 1-N-(4-sulfamoylphenyl-ethyl)-2,4,6-trimethylpyridinium perchlorate, a membrane-impermeant antitumor sulfonamide, is reported. The phenylethyl moiety fills the active site, making van der Waals interactions with side chains of Gln192, Val121, Phe131, Leu198, Thr200. The 2,4,6-trimethylpyridinium. functionality is at van der Waals distance from the aliphatic chain of Ile91. being involved in strong offset face-to-face stacking with Phe131. Analyzing X-ray crystal structures of such adducts, two binding modes were observed: some inhibitors bind with their tail within the hydrophobic half of the active site, defined by residues Phe131, Val135, Leu198, Pro202, Leu204. Other derivatives bind with their tail in a different region, pointing toward the hydrophilic half and making strong parallel stacking with Phe131. This interaction orients the inhibitor toward the hydrophilic part of the active site. Impossibility to participate in it leads to its binding within the hydrophobic half. Such findings are relevant for designing better inhibitors targeting isozymes II, IX, and XII, some of which are overexpressed in hypoxic tumors.
引用
收藏
页码:5721 / 5727
页数:7
相关论文
共 53 条
[51]   Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: New pharmacological opportunities due to related binding site recognition [J].
Weber, A ;
Casini, A ;
Heine, A ;
Kuhn, D ;
Supuran, CT ;
Scozzafava, A ;
Klebe, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (03) :550-557
[52]   Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with bis-sulfamates [J].
Winum, JY ;
Pastorekova, S ;
Jakubickova, L ;
Montero, JL ;
Scozzafava, A ;
Pastorek, J ;
Vullo, D ;
Innocenti, A ;
Supuran, CT .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) :579-584
[53]   Sulfamates and their therapeutic potential [J].
Winum, JY ;
Scozzafava, A ;
Montero, JL ;
Supuran, CT .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (02) :186-228